PMID- 33679743 OWN - NLM STAT- MEDLINE DCOM- 20210702 LR - 20221207 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 12 DP - 2021 TI - IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T Cell Activation Through LAG-3 Expression. PG - 607315 LID - 10.3389/fimmu.2021.607315 [doi] LID - 607315 AB - Dendritic cells (DCs) are professional antigen-presenting cells involved in the initiation of immune responses. We generated a tolerogenic DC (tolDC) line that constitutively secretes interleukin-10 (IL10-DCs), expressed lower levels of co-stimulatory and MHCII molecules upon stimulation, and induced antigen-specific proliferation of T cells. Vaccination with IL10-DCs combined with another tolDC line that secretes IL-35, reduced antigen-specific local inflammation in a delayed-type hypersensitivity assay independently on regulatory T cell differentiation. In an autoimmune model of rheumatoid arthritis, vaccination with the combined tolDCs after the onset of the disease impaired disease development and promoted recovery of mice. After stable memory was established, the tolDCs promoted CD4 downregulation and induced lymphocyte activation gene 3 (LAG-3) expression in reactivated memory T cells, reducing T cell activation. Taken together, our findings indicate the benefits of combining anti-inflammatory cytokines in an antigen-specific context to treat excessive inflammation when memory is already established. CI - Copyright (c) 2021 Koga, Engel, Pigni, Lavanchy, Stevanin, Laversenne, Schneider and Acha-Orbea. FAU - Koga, Marianna M AU - Koga MM AD - Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne, Lausanne, Switzerland. FAU - Engel, Adrien AU - Engel A AD - Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne, Lausanne, Switzerland. FAU - Pigni, Matteo AU - Pigni M AD - Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne, Lausanne, Switzerland. FAU - Lavanchy, Christine AU - Lavanchy C AD - Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne, Lausanne, Switzerland. FAU - Stevanin, Mathias AU - Stevanin M AD - Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne, Lausanne, Switzerland. FAU - Laversenne, Vanessa AU - Laversenne V AD - Brain Mind Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland. FAU - Schneider, Bernard L AU - Schneider BL AD - Brain Mind Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland. AD - Bertarelli Platform for Gene Therapy, Ecole Polytechnique Federale de Lausanne, Geneva, Switzerland. FAU - Acha-Orbea, Hans AU - Acha-Orbea H AD - Department of Biochemistry, Center of Immunity and Infection Lausanne, University of Lausanne, Lausanne, Switzerland. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210217 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Antigens, CD) RN - 0 (Cytokines) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Il12a protein, mouse) RN - 0 (Interleukin-12 Subunit p35) RN - 0 (Vaccines) RN - 130068-27-8 (Interleukin-10) RN - 0 (Lymphocyte Activation Gene 3 Protein) RN - 0 (Lag3 protein, mouse) SB - IM MH - Animals MH - Antigens, CD/*genetics MH - Arthritis, Rheumatoid/immunology/metabolism/pathology/therapy MH - Cell Communication/immunology MH - Cell Line MH - Cytokines/metabolism MH - Dendritic Cells/*immunology/*metabolism MH - Female MH - Gene Expression MH - Histocompatibility Antigens Class II/genetics/immunology MH - Immune Tolerance MH - *Immunologic Memory MH - Immunomodulation MH - Immunotherapy/methods MH - Interleukin-10/*biosynthesis MH - Interleukin-12 Subunit p35/*biosynthesis MH - Lymphocyte Activation/genetics/immunology MH - Mice MH - Mice, Knockout MH - T-Lymphocytes/*immunology/*metabolism MH - Vaccines/administration & dosage/immunology MH - Lymphocyte Activation Gene 3 Protein PMC - PMC7925845 OTO - NOTNLM OT - IL-10 OT - IL-35 OT - LAG-3 OT - dendritic cells OT - tolerogenic DCs COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/03/09 06:00 MHDA- 2021/07/03 06:00 PMCR- 2021/01/01 CRDT- 2021/03/08 05:50 PHST- 2020/09/16 00:00 [received] PHST- 2021/01/26 00:00 [accepted] PHST- 2021/03/08 05:50 [entrez] PHST- 2021/03/09 06:00 [pubmed] PHST- 2021/07/03 06:00 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2021.607315 [doi] PST - epublish SO - Front Immunol. 2021 Feb 17;12:607315. doi: 10.3389/fimmu.2021.607315. eCollection 2021.